REINEKE; Ulrich
Patent Applications and Registrations
Patent applications and USPTO patent grants for REINEKE; Ulrich.The latest application filed is for "compounds comprising a fibroblast activation protein ligand and use thereof".
Company Profile
7.29.29
- REINEKE; Ulrich - Berlin DE
- Reineke; Ulrich - Overath DE
Patent Activity
| Patent | Date |
|---|---|
| Compounds Comprising A Fibroblast Activation Protein Ligand And Use Thereof App 20220273831 - OSTERKAMP; Frank ; et al. | 2022-09-01 |
| TFPI inhibitors and methods of use Grant 11,001,613 - Dockal , et al. May 11, 2 | 2021-05-11 |
| Neurotensin receptor ligands Grant 10,961,199 - Osterkamp , et al. March 30, 2 | 2021-03-30 |
| Neurotensin Receptor Ligands App 20210087149 - OSTERKAMP; Frank ; et al. | 2021-03-25 |
| Conjugate comprising a neurotensin receptor ligand and use thereof Grant 10,799,605 - Osterkamp , et al. October 13, 2 | 2020-10-13 |
| TFPI inhibitors and methods of use Grant 10,800,816 - Dockal , et al. October 13, 2 | 2020-10-13 |
| Tfpi Inhibitors And Methods Of Use App 20190134147 - Dockal; Michael ; et al. | 2019-05-09 |
| TFPI inhibitors and methods of use Grant 10,201,586 - Dockal , et al. Feb | 2019-02-12 |
| NPR-B agonists Grant 10,196,423 - Osterkamp , et al. Fe | 2019-02-05 |
| NPR-B Agonists App 20180334477 - Osterkamp; Frank ; et al. | 2018-11-22 |
| Tfpi Inhibitors And Methods Of Use App 20180155399 - DOCKAL; Michael ; et al. | 2018-06-07 |
| NPR-B agonists Grant 9,982,016 - Osterkamp , et al. May 29, 2 | 2018-05-29 |
| Tfpi Inhibitors And Methods Of Use App 20180072784 - DOCKAL; Michael ; et al. | 2018-03-15 |
| TFPI inhibitors and methods of use Grant 9,873,720 - Dockal , et al. January 23, 2 | 2018-01-23 |
| NPR-B Agonists App 20170313743 - Osterkamp; Frank ; et al. | 2017-11-02 |
| TFPI inhibitors and methods of use Grant 9,777,051 - Dockal , et al. October 3, 2 | 2017-10-03 |
| NPR-B agonists Grant 9,745,344 - Osterkamp , et al. August 29, 2 | 2017-08-29 |
| Tfpi Inhibitors And Methods Of Use App 20170174727 - DOCKAL; MICHAEL ; et al. | 2017-06-22 |
| Tfpi Inhibitors And Methods Of Use App 20170157198 - Dockal; Michael ; et al. | 2017-06-08 |
| Conjugate Comprising A Neurotensin Receptor Ligand And Use Thereof App 20170119913 - Osterkamp; Frank ; et al. | 2017-05-04 |
| TFPI inhibitors and methods of use Grant 9,556,230 - Dockal , et al. January 31, 2 | 2017-01-31 |
| Cyclic peptide-based NPR-B agonists Grant 9,458,198 - Osterkamp , et al. October 4, 2 | 2016-10-04 |
| Novel NPR-B Agonists App 20160194357 - Ostercamp; Frank ; et al. | 2016-07-07 |
| NPR-B agonists Grant 9,169,293 - Osterkamp , et al. October 27, 2 | 2015-10-27 |
| Neurotensin Receptor Ligands App 20150299133 - OSTERKAMP; Frank ; et al. | 2015-10-22 |
| Tfpi Inhibitors And Methods Of Use App 20150232514 - Dockal; Michael ; et al. | 2015-08-20 |
| TFPI inhibitors and methods of use Grant 9,018,167 - Dockal , et al. April 28, 2 | 2015-04-28 |
| TFPI inhibitors and methods of use Grant 8,962,563 - Dockal , et al. February 24, 2 | 2015-02-24 |
| Compounds for the inhibition of integrins and use thereof Grant 8,927,534 - Zischinsky , et al. January 6, 2 | 2015-01-06 |
| Novel Npr-b Agonists App 20130345394 - Osterkamp; Frank ; et al. | 2013-12-26 |
| Tfpi Inhibitors And Methods Of Use App 20130274193 - Dockal; Michael ; et al. | 2013-10-17 |
| Tfpi Inhibitors And Methods Of Use App 20130259863 - Dockal; Michael ; et al. | 2013-10-03 |
| NPR-B agonists Grant 8,546,523 - Osterkamp , et al. October 1, 2 | 2013-10-01 |
| Tfpi Inhibitors And Methods Of Use App 20130252896 - Dockal; Michael ; et al. | 2013-09-26 |
| Compounds for the inhibition of angiogenesis and use thereof Grant 8,501,787 - Zahn , et al. August 6, 2 | 2013-08-06 |
| TFPI inhibitors and methods of use Grant 8,466,108 - Dockal , et al. June 18, 2 | 2013-06-18 |
| TFPI inhibitors and methods of use Grant 8,450,275 - Dockal , et al. May 28, 2 | 2013-05-28 |
| 8-oxy-quinoline derivatives as bradykinin B2 receptor modulators Grant 8,410,134 - Gibson , et al. April 2, 2 | 2013-04-02 |
| Heterocyclic compounds for the inhibition of integrins and use thereof Grant 8,309,735 - Zischinsky , et al. November 13, 2 | 2012-11-13 |
| Tfpi Inhibitors And Methods Of Use App 20120028901 - DOCKAL; MICHAEL ; et al. | 2012-02-02 |
| C5a receptor antagonists Grant 8,071,810 - Schnatbaum , et al. December 6, 2 | 2011-12-06 |
| Novel Npr-b Agonists App 20110077381 - Osterkamp; Frank ; et al. | 2011-03-31 |
| 8-oxy-quinoline Derivatives As Bradykinin B2 Receptor Modulators App 20100234344 - Gibson; Christoph ; et al. | 2010-09-16 |
| Tfpi Inhibitors And Methods Of Use App 20100173847 - Dockal; Michael ; et al. | 2010-07-08 |
| Heterocyclic Compounds For The Inhibition Of Integrins And Use Thereof App 20090203745 - Zischinsky; Gunther ; et al. | 2009-08-13 |
| Compounds For The Inhibition Of Integrins And Use Thereof App 20090104116 - Zischinsky; Gunter ; et al. | 2009-04-23 |
| C5a Receptor Antagonists App 20080220003 - Schnatbaum; Karsten ; et al. | 2008-09-11 |
| Kinin Antagonists For Treating Bladder Dysfunction App 20080221039 - Gibson; Christoph ; et al. | 2008-09-11 |
| Compounds for the inhibition of angiogenesis and use thereof App 20070155712 - Zahn; Grit ; et al. | 2007-07-05 |
| Method of producing a resin bonded moulded part App 20060131792 - Hogenkamp; Wolfgang ; et al. | 2006-06-22 |
| Method and device for the production of brake linings or clutch linings made of pressing materials that are bonded by means of a bonding agent App 20060131774 - Hogenkamp; Wolfgang ; et al. | 2006-06-22 |
| Press App 20060105073 - Hogenkamp; Wolfgang ; et al. | 2006-05-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 